Drug delivery and diagnostic disposables sees a global capacity addition, also witnesses a beginning of strategic alliance between medical device behemoth BD and CTP
Global capacity of drug delivery and diagnostic disposables sees a recent expansion by addition of CTP’s manufacturing facility.
While innovation in drug delivery has been on steady pace, joint alliances between medtech OEMs and contract manufacturers has been pretty much stagnant.
CTP, along with expanding its annual production volume also struck a deal with BD for commercial launch of BD Vystra, a disposable pen for delivering insulin and other injectable drugs. CTP had previously supported Becton Dickinson with pilot phase of Vystra.